Inactive Instrument

Transcripts NeoStem Inc Nasdaq

Stocks

US6406504042

Biotechnology & Medical Research

End-of-day quote Nasdaq
- ^USD	-

09-17	Lisata Therapeutics, Inc.(NasdaqCM:LSTA) added to NASDAQ Composite Index	CI
09-17	Lisata Therapeutics, Inc. (Nasdaq: LSTA) acquired Marea Therapeutics, Inc. for approximately $240 million.	CI

Transcripts

11-06	Lisata Therapeutics, Inc., Q3 2025 Earnings Call, Nov 06, 2025
25-08-07	Lisata Therapeutics, Inc., Q2 2025 Earnings Call, Aug 07, 2025
25-05-08	Lisata Therapeutics, Inc., Q1 2025 Earnings Call, May 08, 2025
25-02-27	Lisata Therapeutics, Inc., 2024 Earnings Call, Feb 27, 2025
24-11-12	Lisata Therapeutics, Inc., Q3 2024 Earnings Call, Nov 12, 2024
24-08-12	Lisata Therapeutics, Inc., Q2 2024 Earnings Call, Aug 12, 2024
24-05-09	Lisata Therapeutics, Inc., Q1 2024 Earnings Call, May 09, 2024
24-04-10	Lisata Therapeutics, Inc. - Special Call
24-02-29	Lisata Therapeutics, Inc., 2023 Earnings Call, Feb 29, 2024
23-11-02	Lisata Therapeutics, Inc., Q3 2023 Earnings Call, Nov 02, 2023
23-08-15	Lisata Therapeutics, Inc., Q2 2023 Earnings Call, Aug 15, 2023
23-06-21	Lisata Therapeutics, Inc. - Special Call
23-05-09	Lisata Therapeutics, Inc., Q1 2023 Earnings Call, May 09, 2023
23-03-30	Lisata Therapeutics, Inc., Q4 2022 Earnings Call, Mar 30, 2023
22-11-10	Lisata Therapeutics, Inc., Q3 2022 Earnings Call, Nov 10, 2022
22-08-14	Caladrius Biosciences, Inc. - Special Call
22-08-04	Caladrius Biosciences, Inc., Q2 2022 Earnings Call, Aug 04, 2022
22-05-24	Caladrius Biosciences, Inc. - Special Call
22-05-05	Caladrius Biosciences, Inc., Q1 2022 Earnings Call, May 05, 2022
22-04-27	Caladrius Biosciences, Inc., Cend Therapeutics Inc. - M&A Call
22-03-22	Caladrius Biosciences, Inc., Q4 2021 Earnings Call, Mar 22, 2022
21-11-04	Caladrius Biosciences, Inc., Q3 2021 Earnings Call, Nov 04, 2021
21-08-05	Caladrius Biosciences, Inc., Q2 2021 Earnings Call, Aug 05, 2021
21-05-06	Caladrius Biosciences, Inc., Q1 2021 Earnings Call, May 06, 2021
21-02-25	Caladrius Biosciences, Inc., Q4 2020 Earnings Call, Feb 25, 2021